Aisling Capital Management LP

NEW YORK, NY · CIK 1766721 · 13F filing filed 2026-08-13

SEC-registered investment adviser since 2015 · limited partnership

As an employer

$471.6m reported value -1.0% vs Q1 2026

14positions

99.0%in top 10

1 new 0 added 1 reduced 0 sold out vs Q1 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	BRIDGEBIO PHARMA INC COM BBIO	BBIO	4,589,611	$341.8m72.48%	72.48%	Reduced -500.0k	-500,000 -9.8%
2	MONTE ROSA THERAPEUTICS INC COM GLUE	GLUE	1,555,664	$37.6m7.98%	7.98%	Unchanged
3	SYNDAX PHARMACEUTICALS INC COM SNDX	SNDX	1,316,806	$28.8m6.10%	6.10%	Unchanged
4	COMPASS PATHWAYS PLC SPONSORED ADS CMPS	CMPS	1,432,336	$20.3m4.30%	4.30%	Unchanged
5	BICARA THERAPEUTICS INC COM BCAX	BCAX	568,919	$16.9m3.58%	3.58%	Unchanged
6	BRIDGEBIO ONCOLOGY THERAPEUT COM NEW BBOT	BBOT	1,018,018	$7.8m1.64%	1.64%	Unchanged
7	SCHOLAR ROCK HLDG CORP COM SRRK	SRRK	77,031	$4.2m0.90%	0.90%	Unchanged
8	UROGEN PHARMA LTD COM URGN	URGN	108,000	$4.0m0.84%	0.84%	Unchanged
9	BIOMEA FUSION INC COM BMEA	BMEA	2,048,757	$3.0m0.64%	0.64%	Unchanged
10	ACLARIS THERAPEUTICS INC COM ACRS	ACRS	434,455	$2.3m0.49%	0.49%	Unchanged
11	EUPRAXIA PHARMACEUTICALS INC COM EPRX	EPRX	325,000	$2.1m0.46%	0.46%	Unchanged
12	VTV THERAPEUTICS INC CL A NEW VTVT	VTVT	50,000	$1.9m0.40%	0.40%	New
13	MARKER THERAPEUTICS INC COM NEW MRKR	MRKR	325,370	$478.3k0.10%	0.10%	Unchanged
14	ONKURE THERAPEUTICS INC COM CL A OKUR	OKUR	88,607	$404.0k0.09%	0.09%	Unchanged